Academic pharmacist Nataly Martini highlights the importance of understanding non-Hodgkin lymphoma and pharmacists’ roles in managing this condition
Friday 1 November 2024, 01:00 AM
14 minutes to Read
Pseudoephedrine became available for over-the-counter sale for the first time in 13 years on 20 May, after the ACT Party delivered on its election promise to undo the 2011 reclassification of the product as a prescription-only medicine. Jonathan Chilton-Towle looks at what pharmacies have experienced since then